A Strain Change Study for SARS-CoV-2 rS Vaccines
Trial details
- Registry ID
- NCT06409663
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as SARS-CoV-2 rS
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Strain Change Study for SARS-CoV-2 rS VaccinesNCT06409663 | Novavax | Phase 3 | Completed | 2024-10-15Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |